Signum Surgical, maker of the BioHealx implant system, announced today that it appointed Carol Burns as its new CEO.
Pivotal milestone follows U.S. FDA De Novo clearance for BioHealx® in 2024. Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology company developing innovative solutions to ...
Signum Surgical, (‘Signum’ or ‘the Company’) the medical technology company developing innovative solutions to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback